Skip to main content

HCA Healthcare, Inc. guidance

  • HCA · NYSE
  • Healthcare
  • Health Care Facilities
  • S&P 500
$511.78+2.55%Close 16 Nov 2026 · Market value $106.0B

HCA Healthcare, Inc. gives no forecast in figures in its latest earnings release (27 Oct 2026). Many companies give their outlook on the call only, or none at all.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Guidance against results above 1 · within 2 · below 0

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
RevenueFY2026$77.00B to $79.50BNarrowed—To come
EPSFY2026$28.70 to $30.50Lowered once—To come
EBITDA · AdjustedFY2026$15.40B to $16.10BLowered once—To come
Capital expendituresFY2026$5.00B to $5.50BUnchanged—To come
RevenueFY2025$74.00B to $76.00BRaised once$75.60BWithin the range
EBITDA · AdjustedFY2025$14.70B to $15.30BRaised once$15.57BAbove the range
Capital expendituresFY2025About $5.00BLowered once$4.94BWithin the range

HCA in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.